ORAL FORMULATION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOLE-5-YL)PYRAZOLE-4-CARBOXYLIC ACID AND METHOD FOR PREPARING SAME

The present invention relates to an oral formulation comprising a high content of an API selected from 1-(3-cyano-1-isopropyl-indole-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof. The oral formulation according to the present invention has a high content and excellent...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, Ree Sun, JANG, Joomyung, SEO, Jin A, YOO, Seok Cheol
Format Patent
LanguageEnglish
Published 25.09.2024
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to an oral formulation comprising a high content of an API selected from 1-(3-cyano-1-isopropyl-indole-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof. The oral formulation according to the present invention has a high content and excellent physical properties by comprising a fluidizing agent from among excipients, and thus can have increased economic efficiency and convenience of administration.
Bibliography:Application Number: ZA20230005155